Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin

文献类型： 外文期刊

第一作者： Wang, Bin

作者： Wang, Bin;Yu, Hai;Yang, Fu-Ru;Huang, Meng;Ma, Ji-Hong;Tong, Guang-Zhi;Wang, Bin;Tong, Guang-Zhi;Wang, Bin

作者机构：

关键词： Swine influenza;DNA vaccine;Consensus HA;M2e;CTL epitope

期刊名称：VIROLOGY JOURNAL （ 影响因子：4.099； 五年影响因子：3.719 ）

ISSN： 1743-422X

年卷期： 2012 年 9 卷

页码：

收录情况： SCI

摘要： Background: Pigs have been implicated as mixing reservoir for the generation of new pandemic influenza strains, control of swine influenza has both veterinary and public health significance. Unlike human influenza vaccines, strains used for commercially available swine influenza vaccines are not regularly replaced, making the vaccines provide limited protection against antigenically diverse viruses. It is therefore necessary to develop broadly protective swine influenza vaccines that are efficacious to both homologous and heterologous virus infections. In this study, two forms of DNA vaccines were constructed, one was made by fusing M2e to consensus H3HA (MHa), which represents the majority of the HA sequences of H3N2 swine influenza viruses. Another was made by fusing M2e and a conserved CTL epitope (NP147-155) to consensus H3HA (MNHa). Their protective efficacies against homologous and heterologous challenges were tested. Results: BALB/c mice were immunized twice by particle-mediated epidermal delivery (gene gun) with the two DNA vaccines. It was shown that the two vaccines elicited substantial antibody responses, and MNHa induced more significant T cell-mediated immune response than MHa did. Then two H3N2 strains representative of different evolutional and antigenic clusters were used to challenge the vaccine-immunized mice (homosubtypic challenge). Results indicated that both of the DNA vaccines prevented homosubtypic virus infections completely. The vaccines' heterologous protective efficacies were further tested by challenging with a H1N1 swine influenza virus and a reassortant 2009 pandemic strain. It was found that MNHa reduced the lung viral titers significantly in both challenge groups, histopathological observation showed obvious reduction of lung pathogenesis as compared to MHa and control groups. Conclusions: The combined utility of the consensus HA and the conserved M2e and CTL epitope can confer complete and partial protection against homologous and heterologous challenges, respectively, in mouse model. This may provide a basis for the development of universal swine influenza vaccines.

分类号：

  • 相关文献

[1]Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles. Zhao, Kai,Shi, Xingming,Zhao, Yan,Wei, Haixia,Huang, Tingting,Zhang, Xiaoyan,Wang, Yunfeng,Zhao, Kai,Wei, Haixia,Sun, Qingshen,Huang, Tingting,Zhang, Xiaoyan. 2011

[2]An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge. Ma, Ji-Hong,Yang, Fu-Ru,Yu, Hai,Zhou, Yan-Jun,Li, Guo-Xin,Huang, Meng,Wen, Feng,Tong, Guangzhi. 2013

[3]Interactive mechanism between avian infectious bronchitis S1 protein T cell peptide and avian MHC I molecule. Zhu, Feng-zhu,Huang, Qing-hua,Huang, Yan-yan,Yang, Shao-hua,Liu, Chang,Xu, Chuan-tian,Zhu, Feng-zhu,Cui, Yan-shun,Tan, Liugang,Kong, Zhengjie,Luci, Mei.

[4]Isolation and genetic analysis of human origin H1N1 and H3N2 influenza viruses from pigs in China. Yu, Hai,Zhang, Gui-Hong,Hua, Rong-Hong,Zhang, Qiang,Liu, Tian-Qiang,Liao, Ming,Tong, Guang-Zhi.

[5]Further evidence for infection of pigs with human-like H1N1 influenza viruses in China. Yu, Hai,Zhou, Yan-Jun,Li, Guo-Xin,Yan, Li-Ping,Tong, Guang-Zhi,Zhang, Gui-Hong,Liao, Ming,Liu, Hui-Li. 2009

[6]Isolation and genetic characterization of avian-like H1N1 and novel ressortant H1N2 influenza viruses from pigs in China. Zhang, Peng-Chao,Pan, Jie,Shi, Xiao-Xiao,Liu, Hui-Li,Yu, Hai,Zhou, Yan-Jun,Li, Guo-Xin,Yan, Li-Ping,Tong, Guang-Zhi. 2009

[7]Prevalence, genetics, and transmissibility in ferrets of Eurasian avian-like H1N1 swine influenza viruses. Yang, Huanliang,Chen, Yan,Qiao, Chuanling,He, Xijun,Yin, Hang,Meng, Shasha,Liu, Liping,Zhang, Qianyi,Kong, Huihui,Gu, Chunyang,Li, Chengjun,Bu, Zhigao,Chen, Hualan,Zhou, Hong,Sun, Yu,Kawaoka, Yoshihiro.

[8]Novel triple-reassortant H1N1 swine influenza viruses in pigs in Tianjin, Northern China. Sun, Ying-Feng,Li, Xiu-Li,Zhang, Li,Li, Hai-Hua,Lu, Chao,Yang, Chun-Lei,Feng, Jing,Han, Wei,Ren, Wei-Ke,Tian, Xiang-Xue,Yan, Ming-Hua,Wang, Xiu-Hui,Tong, Guang-Zhi,Wen, Feng,Li, Ze-Jun,Gong, Xiao-Qian,Liu, Xiao-Min,Ruan, Bao-Yang,Yu, Hai.

[9]Novel reassortant influenza viruses between pandemic (H1N1) 2009 and other influenza viruses pose a risk to public health. Kong, Weili,Dong, Bin,Meng, Demei,Fan, Zhen-Chuan,Liu, Jinhua,Fan, Zhen-Chuan,Wang, Feibing,Ou, Changbo.

[10]Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice. Chen, Jia,Li, Zhong-Yuan,Huang, Si-Yang,Song, Hui-Qun,Zhou, Dong-Hui,Zhu, Xing-Quan,Chen, Jia,Zhu, Xing-Quan,Petersen, Eskild,Petersen, Eskild. 2014

[11]CpG DNA enhances the immune responses elicited by the DNA vaccine against foot-and-mouth disease virus in guinea pigs. Li, GJ,Li, YJ,Yan, WY,Xu, QX,Wu, YQ,Xie, Y,You, YJ,Zheng, ZX. 2001

[12]Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice. Zhang, Nian-Zhang,Xu, Ying,Wang, Meng,Chen, Jia,Huang, Si-Yang,Zhu, Xing-Quan,Xu, Ying,Petersen, Eskild,Huang, Si-Yang,Zhu, Xing-Quan. 2015

[13]Immune Effect of Newcastle Disease Virus DNA Vaccine with C3d as a Molecular Adjuvant. Zhao, Kai,Duan, Xutong,Hao, Lianwei,Wang, Xiaohua,Zhao, Kai,Duan, Xutong,Wang, Yunfeng. 2017

[14]Combined recombinant DNA vaccine results in significant protection against Mycobacterium tuberculosis. Pan, Y,Cai, H,Li, SX,Tian, X,Li, T,Zhu, YX. 2003

[15]A Streptococcus iniae DNA vaccine delivered by a live attenuated Edwardsiella tarda via natural infection induces cross-genus protection. Sun, Y.,Hu, Y-H.,Sun, L.,Sun, Y.,Liu, C-S.. 2012

[16]Primary studies on immunoprotectivity of Marek's disease virus DNA vaccine. Li, JW,Zhao, XY,Yang, JD,Liu, CJ,Li, X,Tian, ZJ,Xu, YW. 1996

[17]Effects of different cytokines on immune responses of rainbow trout in a virus DNA vaccination model. Cao, Yongsheng,Xu, Liming,Li, Shaowu,Wang, Di,Zhao, Jingzhuang,Liu, Hongbai,Lu, Tongyan,Cao, Yongsheng,Zhang, Qiya,Feng, Jian. 2017

[18]Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice. Chen, Jia,Huang, Si-Yang,Li, Zhong-Yuan,Yuan, Zi-Guo,Zhou, Dong-Hui,Zhang, Nian-Zhang,Zhu, Xing-Quan,Chen, Jia,Li, Zhong-Yuan,Yuan, Zi-Guo,Petersen, Eskild,Petersen, Eskild,Zhu, Xing-Quan. 2013

[19]Construction and immunogenicity of DNA vaccines encoding fusion protein of murine complement C3d-p28 and GP5 gene of porcine reproductive and respiratory syndrome virus. Zhang, Deqing,Xia, Qingxiang,Wang, Xiaolong,Niu, Zhongxiang,Zhang, Deqing,Xia, Qingxiang,Wang, Xiaolong,Niu, Zhongxiang,Wu, Jiaqiang,Liu, Dong,Zhang, Deqing. 2011

[20]Efficient protection of H5N1 influenza virus DNA vaccine delivering by electroporation in mammalian and avian system. Zhang, QZ,Qin, XM,Dong, HL,Liang, R,He, HX,Li, X,Jiang, BY,Liu, XJ,Duan, MX. 2005

作者其他论文 更多>>

微信小程序